Search

You searched for "Enucleation"

3074 results found

OOC (Oxford Ophthalmological Congress) 2024

1 July 2024 -3 July 2024
by Samuel Verdin, Editorial Coordinator, Eye News. We were recently ‘daan saaf’ in England for the wonderfully scientific and long-standing Oxford Ophthalmological Congress for their 107th year! Founding in 1909 by Robert W Doyne, the congress is guided by the...
Experimental Eye Research cover image.

Mast cells in Graves’ ophthalmopathy

1 August 2016 | | EYE - General
Graves’ ophthalmopathy (GO) is a potentially sight-threatening ocular disease, occurring in patients with hyperthyroidism due to Graves’ disease. Also known as thyroid-associated ophthalmopathy, GO is characterised by orbital infiltration by immune cells including macrophages, T cells and plasma cells, which...
British Journal of Ophthalmology cover image.

Microsporidia-induced stromal keratitis: a new cause of presumed immune stromal (interstitial) keratitis

4 December 2023 | | EYE - Cornea, EYE - General
This is a non-comparative retrospective observational case series from India from 1 October 2020 to 31 January 2021. The inclusion criteria were: (1) presence of nummular / coin shaped lesions with at least one >2mm in size and / presence...

Veterans with vision impairment deserve better public transport links says Paisley Councillor

19 May 2023 | Sight Scotland Veterans, VR, SIGHT LOSS, Elderly
Cllr Carolann Davidson, Labour & Cooperative Councillor for Paisley East and Central, recently visited Sight Scotland Veterans’ Hawkhead Centre to see first-hand the great work the charity does in supporting veterans with sight loss.

Glaucoma UK ‘Excellence in Glaucoma Care Award 2024’ Winner Announcement

22 April 2024 | awards, GCU, Glasgow, optometry, opticians, education, Zainab Alrikabi
PhD student at Glasgow Caledonian University wins the Glaucoma UK ‘Excellence in Glaucoma Care Award 2024’.

Ophthalmic surgeon returns to London Marathon after 31 years for Glaucoma UK

30 April 2024 | Glaucoma, charity, event, anniversary, 50th, UK, London, fundraising, i will
Michael Miller, in commemoration of Glaucoma UK's 50th anniversary, has achieved a remarkable feat by completing this year's London Marathon, three decades after he last completed the challenge in 1993, which he also ran in support of the charity.

HASA OPTIX Certifies as a B Corporation

18 December 2024 | Company Profiles
Premium recyclable ophthalmic instrument company HASA OPTIX announces its certification as a B Corporation (B Corp) company. In a press release, the Brussels-based scale-up confirmed its score of 109.7 points on the B Impact Assessment, in which nonprofit B Lab...

My top five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - Vitreo-Retinal
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

My Top Five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - General
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

How effective is nurse-led telephone preassessment for cataract surgery?

25 July 2023 | | EYE - Cataract, EYE - Refractive
Cataract surgery is the most frequently performed surgical procedure in the UK [1]. The demand for cataract surgery is projected to increase with ageing population, and the recent pandemic has further contributed to the extended waiting times in the UK....

An eye on novel anti-cancer agents: an evidence-based approach to external eye assessment

5 April 2022 | | EYE - Cornea, EYE - General
Novel anti-cancer therapies have led to significant advancement in cancer treatment, however, they can be associated with external eye complications. It is important to be mindful of such adverse effects during assessment of patients enrolled in clinical trials. Annually, approximately...

My Top Five: Innovations in the diagnosis of ocular tumours

4 February 2025 | | EYE - Oncology, EYE - Orbit, EYE - Pathology
Ocular tumours can vary widely in origin, from benign growths to metastases from distant disseminated malignancies. Although rare, ocular tumours pose a significant health and economic burden globally, with ocular cancers accounting for 0.2% of all diagnosed malignancies in the...